Best Warren Buffett Companies For 2014

Warren Buffett is usually hands-off when it comes to the companies operating under Berkshire Hathaway's (NYSE: BRK-A  ) (NYSE: BRK-B  ) umbrella, but the Oracle of Omaha decided to step in and shut down a controversial practice at Business Wire.

In this segment of The Motley Fool's financials-focused show, Where the Money Is, banking analysts Matt Koppenheffer and David Hanson discuss Buffett's decision.

More wisdom from Warren Buffett
Warren Buffett has made billions through his investing and he wants you to be able to invest like him. Through the years, Buffett has offered up investing tips to shareholders of Berkshire Hathaway. Now you can tap into the best of Warren Buffett's wisdom in a new special report from The Motley Fool. Click here now for a free copy of this invaluable report.

Best Stocks To Own For 2015: Enzymotec Ltd (ENZY)

Enzymotec Ltd., incorporated on March 08, 1998, is engaged in manufacturing of ingredients and medical foods company. Its technologies, research, and clinical validation process enables the Company to develop differentiated solutions across a variety of products. The Company markets its product portfolio primarily to established global consumer companies and target large and growing consumer health and wellness markets. Its clinically validated products include bio-functional lipid-based compounds designed to address dietary needs, medical disorders and common diseases. The Company operates in two segments: Nutrition and VAYA Pharma. In addition to its existing products, the Company has several other products to address additional indications in the development phase. enzyme processes; lipid modification; lipid analysis; and process technology and development.

Nutrition

The Company�� Nutrition segment develops and manufactures nutritional ingredient products based on lipids, such as phospholipids, which form the structural basis of cell membranes and are easily recognized, incorporated and used by the body. Its customer base for this segment includes formula and nutritional supplement companies such as Biostime and IVC. Its two selling nutritional ingredient products are InFat, a clinically-proven fat ingredient for infant formula, and krill oil. Its other products in this segment are targeted at improving brain health and providing benefits in memory, learning abilities and concentration.

VAYA Pharma

VAYA Pharma, develops, manufactures and sells branded, prescription-only medical foods for the dietary management of patients with certain medical conditions or diseases having special, medically determined nutrient requirements. Although medical foods must be safe and effective as demonstrated in human clinical studies, they do not require the same expensive and time consuming regulatory approval process typical of prescription drugs. In addition to! its existing products, it has several other products to address additional indications in the development phase.

Advisors' Opinion:

• [By Victor Selva]

  Finally, as opposed to what we just discussed, the firm is currently Zacks Rank # 4��ell, and it also has a longer-term recommendation of ��eutral�� A Sell rating indicates that the stock, over the next 1 to 3 months, will perform at an annualized rate of 4.8%, which is not attractive for investors. For investors looking for a Strong Buy Rank, BioLife Solutions, Inc. (BLFS) and Enzymotec Ltd. (ENZY) could be the options.

Best Warren Buffett Companies For 2014: Centene Corporation (CNC)

Centene Corporation provides multi-line healthcare programs and services in the United States. It operates in two segments, Medicaid Managed Care and Specialty Services. The Medicaid Managed Care segment provides Medicaid and Medicaid-related health plan coverage to individuals through government subsidized programs, including Medicaid, the State children�s health insurance program, long-term care, foster care, and Medicare special needs plans, as well as aged, blind, or disabled programs. Its health plans provide primary and specialty physician care, inpatient and outpatient hospital care, transportation assistance, emergency and urgent care, vision care, prenatal care, dental care, laboratory and x-ray services, immunizations, prescriptions and over-the-counter drugs, home health and durable medical equipment, behavioral health and substance abuse services, therapies, social work services, care coordination, and 24-hour nurse advice line. The Specialty Services segment manages behavioral healthcare for members; provides health insurance to individual customers and their families; implements life and health management programs; offers long-term care services to the elderly and people with disabilities; and administers routine and medical surgical eye care benefits through its network of eye care providers. It also offers telehealth services; and claims processing, pharmacy network management, benefit design consultation, drug utilization review, formulary and rebate management, specialty and mail order pharmacy services, and patient and physician intervention services, as well as provides care management solutions that automate the clinical, administrative, and technical components of care management programs. The company offers its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Centene (NYSE: CNC  ) , whose recent revenue and earnings are plotted below.

• [By Holly LaFon]

  Importantly, we like the industry in which Centene (CNC) competes. Some of our investors might recall that one of our prior investments, Amerigroup, was acquired in 2012 by Wellpoint at a val uation that allowed us to achieve a return on investment of greater than 100% over the roughly one - year time period that we owned the shares. Medicaid managed care companies not only save states money but also offer better service; therefore, more states a re letting managed care companies run their Medicaid programs. To that end, states are expanding both the geographies carved out to managed care companies and the types of programs. The next phase of growth will come from the dual - eligible population. D uals (or dual - eligible population) are 8.3mm 3 people in the U.S. that are eligible to receive both Medicare and Medicaid benefits (mainly low - income seniors). According to the Kaiser Foundation, Duals accounted for almost 40% of Medicaid spending although they made up only 15% of the Medicaid population. We believe there are ample growth opportunities for CNC and other companies to meet the challenges of managing these disparate Medicaid members for the foreseeable future.

Best Warren Buffett Companies For 2014: Heico Corporation (HEI)

HEICO Corporation, through its subsidiaries, designs, manufactures, and sells aerospace, defense, and electronic related products and services in the United States and internationally. The company�s Flight Support Group segment provides jet engine and aircraft component replacement parts; thermal insulation blankets and parts; and specialty components for aerospace and industrial original equipment manufacturers, and the United States government. This segment also distributes hydraulic, pneumatic, mechanical, and electro-mechanical components for the commercial, regional, and general aviation markets; and offers repair and overhaul services for jet engine and aircraft component parts, avionics, instruments, composites, and flight surfaces of commercial airlines, as well as for avionics and navigation systems, subcomponents, and other instruments utilized on military aircrafts. Its Electronic Technologies Group segment provides a range of electronic, microwave, and electro -optical products, including infrared simulation and test equipment, laser rangefinder receivers, electrical and back-up power supplies, power conversion products, underwater locator beacons, electromagnetic and radio frequency interference shielding, capacitor charging power supplies, amplifiers, traveling wave tube amplifiers, photo detectors, amplifier modules, and microwave power modules. This segment also offers flash lamp and laser diode drivers, arc lamp power supplies, cable assemblies, high voltage power supplies, high voltage interconnection devices and wires, high voltage energy generators, and high frequency power delivery systems. Its products link devices, such as telemetry receivers, digital cameras, high resolution scanners, simulation systems, and test systems to computer for the U.S. and foreign military agencies, prime defense contractors, and commercial and defense satellite and spacecraft manufacturers. The company was founded in 1949 and is headquartere d in Hollywood, Florida.

Advisors' Opinion:

• [By Shauna O'Brien]

  Heico Corp (HEI) announced on Thursday that it has agreed to purchase Lucix Corp, a manufacturer of military satellite, airborne, and ground systems.

  The terms of the deal were not disclosed, but HEI revealed that the acquisition could be completed within 60 days. The deal is expected to impact HEI’s earnings within the first year.

  Heico shares were up 67 cents, or 1.04%, during Thursday morning trading. The stock is up 46% YTD.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on HEICO (NYSE: HEI  ) , whose recent revenue and earnings are plotted below.

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, jet engine replacement parts manufacturer HEICO (NYSE: HEI  ) has earned a coveted five-star ranking.

• [By Jonathan Morgan]

  HeidelbergCement AG (HEI) added 3.2 percent after JPMorgan Chase & Co. upgraded the shares. Puma SE (PUM) slipped 1.6 percent after Europe�� second-largest sporting-goods maker reported earnings before interest and taxes for the second quarter that missed analysts��estimates.

Best Warren Buffett Companies For 2014: Momenta Pharmaceuticals Inc.(MNTA)

Momenta Pharmaceuticals, Inc., a biotechnology company, specializes in the characterization and process engineering of complex molecules. These complex molecules include proteins; polypeptides; and cell surface polysaccharides, such as heparan-sulfate proteoglycans (HSPGs). The company applies its technology for the development and commercialization of generic versions of complex drug products, as well as for the discovery and development of novel drugs. It offers Enoxaparin sodium injection, a generic version of Lovenox to prevent and treat deep vein thrombosis, and to support the treatment of acute coronary syndromes. The company?s products also include M356, an abbreviated new drug application under FDA review, is a generic version of Copaxone for the reduction of the frequency of relapses in patients with relapse-remitting multiple sclerosis; M118, which completed a Phase IIa clinical trial as an anticoagulant for acute coronary syndromes; and M402, a novel HSPG-based product candidate that is in preclinical development as a potential anti-cancer agent. It has collaboration agreements with Sandoz AG and Sandoz Inc. to develop and commercialize Enoxaparin sodium injection. The company was formerly known as Mimeon, Inc. and changed its name to Momenta Pharmaceuticals, Inc. in September 2002. Momenta Pharmaceuticals, Inc. was founded in 2001 and is based in Cambridge, Massachusetts.

Advisors' Opinion:

• [By Maxx Chatsko]

  Building momentum
  It may not seem too impressive on the surface, but Momenta Pharmaceuticals (NASDAQ: MNTA  ) has the makings of a game-changing biotech company. The company has developed a novel platform that greatly speeds the development and characterization of complex biological compounds. Unlike more traditional small molecules, therapeutic proteins are massive molecules whose exact chemical structure and makeup can vary from one production method to the other. Simple folds of subunits within the protein can drastically affect its efficacy and toxicity.

• [By James Brumley]

  Just bear in mind this is largely an all-or-nothing bet on the drug, though PRAN stock could rally nicely leading up to its D-Day approval.

  Momenta Pharmaceuticals (MNTA)

  Like Sagent Pharmaceuticals, Momenta Pharmaceuticals (MNTA) is a generic drugmaker. And also like Sagent, priced at $16.14 per share, MNTA stock is easily put into the cheap stocks category.

• [By Dan Caplinger]

  Lately, the stock market has turned on every word from the Federal Reserve, and so this morning's comments from Federal Reserve Chairwoman Janet Yellen received a huge amount of attention from investors Monday. With Yellen offering a much more encouraging assessment of how long interest rates might remain low in order to stimulate and sustain economic growth, stocks climbed sharply, with the Dow posting triple-digit gains. Yet for MannKind (NASDAQ: MNKD  ) , Momenta Pharmaceuticals (NASDAQ: MNTA  ) , and Idera Pharmaceuticals (NASDAQ: IDRA  ) , the news today was far from good, as all three stocks suffered declines of 10% or more.

• [By Maxx Chatsko]

  Shares of biotech innovator Momenta Pharmaceuticals (NASDAQ: MNTA  ) entered into a nosedive in early June, but quickly recovered after analysts at UBS AG upgraded the stock from "neutral" to "buy." I don't put any faith in analyst projections -- and neither should you -- but I do see value in the company's technology. Momenta has developed a platform for analyzing and characterizing complex molecules that could significantly reduce R&D costs and development times of drugs in the pipeline. If you're an investor looking for a biotech company with boatloads of potential, you may be wondering about adding Momenta to your portfolio. Fool contributor Maxx Chatsko breaks down that decision for investors in the following video.

Best Warren Buffett Companies For 2014: Market Vectors Global Alternative Energy ETF (GEX)

Market Vectors-Global Alternative Energy ETF (the Fund) seeks to replicate as closely as possible the price and yield performance of the Ardour Global Index (Extra Liquid) (the Index). The Index, published by Ardour Global Indexes, LLC and calculated by Dow Jones Indexes, is a benchmark for the global alternative energy industry. The Index is a rules-based index that seeks to track the overall performance of a global universe of listed companies engaged in the alternative energy industry. As of April 2007, the Index consisted of publicly traded stocks of 30 of the largest, most actively traded alternative energy companies from worldwide. Companies included in the Index generate over 50% of their revenues from alternative energy and/or related technologies, and are engaged in five core industry sectors: alternative energy resources (solar, wind, bio-fuels, water and geothermal), which constitute approximately 70% of the Index; distributed generation, which constitutes approximately 3% of the Index; environmental technologies related to alternative energy, which constitutes approximately 9% of the Index; energy efficiency, which constitutes approximately 4% of the Index, and enabling technologies, which constitutes approximately 14% of the Index.

The Index consists of the 30 stocks in the Ardour Global Index (Composite) with the highest average of daily trading volume and market capitalization. The Ardour Global Index (Composite) is a modified capitalization-weighted, float-adjusted index comprising publicly traded companies engaged in the production of alternative fuels and/or technologies related to the production of alternative energy power. The Fund will normally invest at least 80% of its total assets in stocks of companies primarily engaged in the business of alternative energy. The Fund, utilizing a passive or indexing investment approach, attempts to approximate the investment performance of the Index by investing in a portfolio of securities that generally replicate the Index. The ! Fund will hold all of the securities, which comprise the Index in proportion to their weightings in the Index. The Fund will normally invest at least 95% of its total assets in securities that comprise the Index. Van Eck Associates Corporation serves as the investment advisor of the Fund.

Advisors' Opinion:

• [By Todd Shriber, ETF Professor]

  The news was predictably good for a pair of ETFs that should be known as "Tesla ETFs." The Market Vectors Global Alternatve Energy ETF (NYSE: GEX) and the First Trust NASDAQ Clean Edge Green Energy Index Fund (NASDAQ: QCLN) both traded higher on a down day for U.S. stocks, rising to within pennies of their previous 52-week highs.

Best Warren Buffett Companies For 2014: Korn/Ferry International (KFY)

Korn/Ferry International, together with its subsidiaries, provides talent management solutions that help clients to design strategies in building and attracting their talent. It operates in three segments: Executive Recruitment, Leadership & Talent Consulting (LTC), and High-Impact Recruitment Solutions. The Executive Recruitment segment focuses on recruiting board-level, chief executive, and other senior executive positions primarily in the consumer, financial services, and industrial, as well as in life sciences/healthcare, and technology industries. The LTC segment provides leadership and talent management solutions to assist clients with their ongoing assessment, organizational design, and leadership development efforts. The High-Impact Recruitment Solutions segment engages in enterprise-wide consulting and recruitment solutions, including recruitment process outsourcing, talent acquisition and management consulting services, project-based recruitment, mid-level recrui tment, and interim professionals. The company serves public and private companies, middle market and emerging growth companies, government agencies, and nonprofit organizations in North America, Europe, the Middle East, Africa, the Asia Pacific, and South America. Korn/Ferry International was founded in 1969 and is headquartered in Los Angeles, California.

Advisors' Opinion:

• [By Anna Prior]

  Korn/Ferry International's(KFY) fiscal second-quarter profit surged due in large part to a big revenue boost in the company’s leadership and talent consulting business, as well as a favorable comparison to the year-ago period. Shares rose 5.3% to $23.70 premarket as the company’s earnings beat its expectations.

• [By WWW.DAILYFINANCE.COM]
  Stocks ended a mini-losing streak on Friday, led by upbeat news from Intel (INTC). The Dow Jones industrial average (^DJI) rose 41 points, after sliding more than 200 over the previous two days. The Nasdaq composite (^IXIC) gained 13 and the Standard & Poor's 500 index (^GPSC) added 6 points. Those modest gains did little to trim the loss for the week. The major averages posted their biggest weekly declines in more than two months. Intel is a component of all three big indexes, and it jumped 7 percent after raising its revenue guidance for the current quarter. The company sees stronger business demand for PCs than it previously expected. Intel shares are up 23 percent over the past six months. The Intel news had a ripple effect. Computer maker Hewlett-Packard (HPQ) rose more than 5 percent and Microsoft (MSFT) gained 1½ percent. Part of the increased demand Intel points to is tied to corporate buyers who need to replace their Windows XP machines, because Microsoft has stopped providing technical support for that platform. But Apple (AAPL) lost more than 1 percent. The stock is down since its 7-for-1 stock split took effect on Monday. There were two other big stories that had some legs beyond the companies directly involved. Open Table (OPEN) agreed to be acquired by Priceline (PCLN) for $2.6 billion. Open Table, which provides restaurant reservations, jumped 48 percent. Other online service providers rode the coattails of that deal. Yelp (YELP) gained 14 percent and Groupon (GRPN) gained 4 percent. In the retail arena, Express (EXPR) jumped 21 percent after a private equity firm took a 9.9 percent stake in the teen retailer and indicated it may make a buyout offer. That gave a boost to Aeropostale (ARO) and American Eagle (AEO), which both rose more than 2 percent. Abercrombie & Fitch (ANF) gained 1½. Elsewhere, International Game Technology (IGT) gained 10½ percent on a Reuters report that a bidding war could erupt for
• [By DAILYFINANCE]

  Brian Smale/Microsoft via Getty ImagesNewly named Microsoft CEO Satya Nadella. SAN FRANCISCO -- After compiling a list of more than 100 CEO candidates, Microsoft settled on Satya Nadella a homegrown leader who joined the software maker in the early 1990s. That's back when Google's founders were teenagers and Facebook CEO Mark Zuckerberg was in elementary school. Tuesday's hiring of Nadella as Microsoft's CEO after a five-month search is a safe move that's likely to be greeted with sighs of relief around the company's Redmond, Wash., headquarters, industry analysts say. But the methodical, almost predictable decision is likely to reinforce perceptions that Microsoft (MSFT) is a plodding company reluctant to take risks as it competes against younger rivals who relish going out on a limb. While Google (GOOG) founder and CEO Larry Page boasts about his company taking "moon shots" and Zuckerberg promises to "move fast and break things," Microsoft has fallen behind the technological curve after underestimating the importance of Internet search more than a decade ago and reacting too slowly to the rise of mobile devices during the past seven years. Meanwhile, the sales of personal computers running on Microsoft's Windows software are shrinking. Microsoft's malaise may have narrowed the field of up-and-coming visionaries interested in running a company founded in 1975. Just as Microsoft founder Bill Gates and Apple (AAPL) founder Steve Jobs would never have considered working at IBM (IBM) in the 1980s, today's entrepreneurial whiz kids scoff at Microsoft's overtures. "Going to work at Microsoft could make it look like you are going back to the dark ages," says Richard Metheny, a management coach for the executive search firm Witt/Kieffer in Chicago. "It's a well-entrenched business that has had trouble lately figuring out how to play in this new world." Despite its challenges, Microsoft remains a moneymaking machine that sits atop an $84 billion cash pile. Tha